| Title |
Identification and Characterization of Nucleolin as a COUP-TFII Coactivator of Retinoic Acid Receptor β Transcription in Breast Cancer Cells
|
|---|---|
| Published in |
PLOS ONE, May 2012
|
| DOI | 10.1371/journal.pone.0038278 |
| Pubmed ID | |
| Authors |
Lacey M. Litchfield, Krista A. Riggs, Alyson M. Hockenberry, Laura D. Oliver, Katelyn G. Barnhart, Jian Cai, William M. Pierce, Margarita M. Ivanova, Paula J. Bates, Savitri N. Appana, Susmita Datta, Piotr Kulesza, Jean McBryan, Leonie S. Young, Carolyn M. Klinge |
| Abstract |
The orphan nuclear receptor COUP-TFII plays an undefined role in breast cancer. Previously we reported lower COUP-TFII expression in tamoxifen/endocrine-resistant versus sensitive breast cancer cell lines. The identification of COUP-TFII-interacting proteins will help to elucidate its mechanism of action as a transcriptional regulator in breast cancer. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 2% |
| China | 1 | 2% |
| Germany | 1 | 2% |
| France | 1 | 2% |
| Unknown | 60 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 18 | 28% |
| Student > Ph. D. Student | 15 | 23% |
| Student > Master | 5 | 8% |
| Student > Bachelor | 4 | 6% |
| Professor | 4 | 6% |
| Other | 10 | 16% |
| Unknown | 8 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 18 | 28% |
| Biochemistry, Genetics and Molecular Biology | 17 | 27% |
| Medicine and Dentistry | 8 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 9% |
| Business, Management and Accounting | 1 | 2% |
| Other | 5 | 8% |
| Unknown | 9 | 14% |